floatz
Floatz provides scientific diligence and intelligence for life-science investors, pharma business development, and biotech professionals. It consolidates scattered scientific evidence into clear, actionable insights to support in-licensing, mergers and acquisitions, and investment decisions.
What sets Floatz apart is its combination of self-learning AI agents, a life science knowledge graph, and living reports that enable deep scientific search, expert-level reasoning, and contextualized evidence evaluation. This approach highlights development risks, detects evidence gaps, and standardizes portfolio analysis.
By transforming complex scientific data into defensible intelligence, Floatz helps users identify high-value assets and benchmark candidates effectively. Its focus on guiding investments toward promising therapeutics makes it a specialized tool for life-science deal-making and portfolio management.
Floatz integrates claim-to-source referencing and evidence gap detection to ensure reliability. The platform supports portfolio-level standardization and risk identification, providing a comprehensive view of scientific and development factors relevant to investment decisions.
🤖 Self-learning AI agents perform deep scientific searches and expert reasoning
🔗 Life Science Knowledge Graph links findings into a contextual evidence system
📊 Living Reports allow exploration of research insights and evidence gaps
⚠️ Identifies development risks before licensing or investment decisions
📈 Standardizes portfolio analysis for benchmarking and comparison
Transforms complex scientific data into clear, actionable intelligence
Integrates AI reasoning with contextual evidence evaluation
Helps identify risks and evidence gaps before investment decisions
Supports portfolio-level standardization and benchmarking
Tailored for life-science investors and pharma business development
Pricing details are not publicly disclosed; requires contact for demo
Primarily focused on life-science investment, less suited for general academic research
How does Floatz support life-science investment decisions?
Floatz analyzes scientific evidence using AI to identify risks and benchmark assets, helping investors make informed and defensible decisions.
What industries benefit most from Floatz?
Pharma business development, biotech companies, and life-science investors use Floatz for scientific diligence and portfolio evaluation.
What is the Floatz Engine?
Floatz Engine combines AI agents for deep search, a life science knowledge graph linking evidence, and living reports for exploring research insights.
Can Floatz detect gaps in scientific evidence?
Floatz identifies evidence gaps to highlight missing or incomplete data relevant to investment or licensing decisions.
Does Floatz provide risk assessment for drug development?
Floatz surfaces development risks early to help users evaluate potential challenges before in-licensing or investing.
Is Floatz suitable for academic researchers?
Floatz is primarily designed for life-science investors and industry professionals rather than academic research.
How can I get a demo of Floatz?
You can request a demo by contacting Floatz through their website's book-demo page.

